BRIEF published on 04/30/2025 at 18:05, 7 months 4 days ago Neovacs fundraising: a 0.25 million euro operation Biotechnology Fundraising Shareholder Dilution Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 7 months 17 days ago Fundraising of 0.25 Million Euros by Neovacs Fundraising Shareholder Dilution Biotech Néovacs OCEANE-BSA
BRIEF published on 04/16/2025 at 08:05, 7 months 18 days ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/02/2025 at 20:05, 8 months 2 days ago Adjustment of the nominal value of Neovacs shares Shareholders Capital Reduction Dilutive Financing Nominal Value Néovacs
BRIEF published on 03/28/2025 at 08:05, 8 months 7 days ago Neovacs organizes a meeting on Lipid Nanoparticles and RNA Lipid Nanoparticles Innovative Therapies Messenger RNA Néovacs Scientific Meeting
BRIEF published on 03/25/2025 at 08:05, 8 months 10 days ago NEOVACS: Amendment to the trust agreement to optimize financing Funding Investment Trust Néovacs Simple Bonds
BRIEF published on 03/17/2025 at 20:05, 8 months 18 days ago Fundraising of €0.25 million by Neovacs Biotechnology Fundraising Shareholder Dilution OCEANE-BSA Kinoid®
BRIEF published on 03/14/2025 at 18:35, 8 months 21 days ago NEOVACS: Update on voting rights and shares Share Capital Voting Rights Actions Dilution Néovacs
BRIEF published on 03/06/2025 at 08:05, 8 months 29 days ago Neovacs seeks partners for its clinical development Partnership Messenger RNA Néovacs Valorization Allergies
BRIEF published on 02/04/2025 at 08:05, 10 months ago Neovacs considers an exit from the stock market to optimize its assets Investors Funding Biopharmaceutical Arnity Exit From The Stock Exchange
Published on 12/05/2025 at 02:35, 4 hours 42 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 17 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 12 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 17 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 16 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 1 minute ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 17 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 32 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 32 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
